HomeDARE • NASDAQ
Follow
Dare Bioscience Inc
Previous close
$0.55
Day range
$0.49 - $0.56
Year range
$0.27 - $1.10
Market cap
48.23M USD
Avg Volume
505.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 1.00M | — |
Operating expense | 9.37M | 31.74% |
Net income | -8.30M | -18.22% |
Net profit margin | -829.91 | — |
Earnings per share | -0.09 | -12.50% |
EBITDA | -8.39M | -17.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.89M | -65.60% |
Total assets | 25.05M | -50.27% |
Total liabilities | 27.34M | 13.77% |
Total equity | -2.29M | — |
Shares outstanding | 98.56M | — |
Price to book | -27.45 | — |
Return on assets | -86.98% | — |
Return on capital | 929.13% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -8.30M | -18.22% |
Cash from operations | -7.97M | -192.72% |
Cash from investing | -22.10K | 59.82% |
Cash from financing | 8.58M | 192,365.93% |
Net change in cash | 565.32K | -93.20% |
Free cash flow | -2.53M | -122.72% |
About
Founded
2005
Headquarters
Website
Employees
25